ArticleFrontiers in oncology2025

Ultrasound-guided percutaneous radiofrequency ablation combined with anti-PD-1 for the treatment of prostate cancer: an experimental study.

Si Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.